Financhill
Back

Blueprint Medicines Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
31

BPMC
Blueprint Medicines

Last Price:
$88.24
Seasonality Move:
2.07%
Sell
42

NBY
NovaBay Pharmaceuticals

Last Price:
$0.60
Seasonality Move:
10.03%
Sell
31
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $87.22. The Score for BPMC is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.60. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $87.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.60
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.52 Sell
Relative Strength Index (14 RSI): 37.75 Sell
Chaikin Money Flow: 85830 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.18 - 96.26) Sell
Bollinger Bands (100): (87.37 - 95.71) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 53.7 Buy
Chaikin Money Flow: 57304 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.54 - 0.6) Buy
Bollinger Bands (100): (0.49 - 0.69) Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.37 Sell
20-day SMA: 92.65 Sell
50-day SMA: 92.51 Sell
200-day SMA: 96.69 Sell
8-day EMA: 89.52 Sell
20-day EMA: 91.55 Sell
50-day EMA: 92.48 Sell
200-day EMA: 91.6 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.55 Buy
20-day SMA: 0.56 Buy
50-day SMA: 0.63 Sell
200-day SMA: 1.75 Sell
8-day EMA: 0.57 Buy
20-day EMA: 0.57 Buy
50-day EMA: 0.63 Sell
200-day EMA: 4.46 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $2.93 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $0.44 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):